Latest News & Features
Americas
Stem cell research companies in Canada and Australia have teamed up to support increased research and development in both countries. 16 June 2014
Americas
Drug giant Merck is to acquire biopharmaceutical company Idenix for $24.50 per share, valuing the purchase at around $3.85 billion. 12 June 2014
Big Pharma
Law firm Dechert LLP has appointed Rüdiger Herrmann as a partner in its Frankfurt office. 10 June 2014
Generics
Irish-based drug manufacturer Actavis has settled its patent dispute with Zydus Pharmaceuticals. 10 June 2014
Biotechnology
Kite Pharma, a biotech company, has entered into a licensing agreement with the US’s National Institute of Health that will give it the IP rights to T-cell therapies developed to treat cancer. 9 June 2014
Americas
AMAG Pharmaceuticals, Inc. has had a US patent covering ferumoxytol extended. 9 June 2014
Big Pharma
Pharmaceutical professionals should have a “wide-ranging” debate on how IP can be tailored in the face of “major changes” to the industry, including the possibility of “prolonged exclusivity” for certain medicines, according to a report. 6 June 2014
Americas
Pfizer and Mylan have agreed to settle litigation related to arthritis treatment Celebrex (celecoxib), Mylan announced today, June 2. 2 June 2014
Europe
London’s MedCity is working to boost collaboration between businesses in the area and invigorate the UK’s so-called ‘golden triangle’ life sciences cluster, with its three major centres in London, Oxford and Cambridge. LSIPR heard from Eliot Forster, who chairs MedCity, about the initiative. 30 May 2014
Americas
With the Federal Circuit relying on the precedent set by the Prometheus and Myriad decisions, Dolly the sheep has been summarily declared ineligible for patent protection. Nabeela Rasheed sums up the implications. 30 May 2014